Cargando…

Platelet–lymphocyte ratio is a prognostic marker in small cell lung cancer—A systemic review and meta-analysis

AIM: The aim of this study was to evaluate the relationship between platelet–lymphocyte ratio (PLR) and prognosis in small cell lung cancer (SCLC) patients. METHOD: A comprehensive search was carried out to collect related studies. Two independent investigators extracted the data of hazard ratio (HR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Hongbin, Li, Jiuke, Zhang, Yiting, Chen, Zhewen, Chen, Ying, Ye, Sa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880219/ https://www.ncbi.nlm.nih.gov/pubmed/36713502 http://dx.doi.org/10.3389/fonc.2022.1086742

Ejemplares similares

Nitric oxide in occurrence, progress and therapy of lung Cancer: a systemic review and meta-analysis
por: Zhou, Hongbin, et al.
Publicado: (2021)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis
por: Zhang, Feng, et al.
Publicado: (2020)

Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis
por: Leng, Jiali, et al.
Publicado: (2022)

Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis
por: Wang, Xingmu, et al.
Publicado: (2019)

Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in laryngeal cancer: What should we expect from a meta-analysis?
por: Hu, Xianyang, et al.
Publicado: (2022)

The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer
por: Ma, Aiping, et al.
Publicado: (2022)

The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis
por: Ye, Sa, et al.
Publicado: (2016)

Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis
por: Qi, Xue, et al.
Publicado: (2023)

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2019)

Combination of Systemic Inflammation Response Index and Platelet-to-Lymphocyte Ratio as a Novel Prognostic Marker of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy
por: Zheng, Yangqin, et al.
Publicado: (2019)

Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Rugambwa, Tibera K., et al.
Publicado: (2023)

Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
por: Ni, Liwei, et al.
Publicado: (2019)

Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis
por: Zhou, Ke, et al.
Publicado: (2022)

Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
por: Bayraktaroglu, Mesut, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Markers for Advanced Non-Small-Cell Lung Cancer Treated with Immunotherapy: A Systematic Review and Meta-Analysis
por: Platini, Hesti, et al.
Publicado: (2022)

Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
por: Ge, Ming-Yang, et al.
Publicado: (2023)

Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer
por: Pirlog, Cristina-Florina, et al.
Publicado: (2022)

High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated With Sarcopenia Risk in Hospitalized Renal Cell Carcinoma Patients
por: Hu, Qiang, et al.
Publicado: (2021)

Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis
por: Hu, Kaimin, et al.
Publicado: (2015)

Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis
por: Qiang, Guangliang, et al.
Publicado: (2016)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy
por: Kutlu, Yasin, et al.
Publicado: (2023)

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
por: Song, Xinyu, et al.
Publicado: (2018)

Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma
por: Zhang, Tiantian, et al.
Publicado: (2023)

Preoperative lymphocyte-to-monocyte ratio versus platelet-to-lymphocyte ratio as a prognostic predictor for non-small cell lung cancer patients
por: Yan, Haixi, et al.
Publicado: (2020)

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes
por: Chen, Qiuni, et al.
Publicado: (2022)

High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates
por: Karakaya, Serdar, et al.
Publicado: (2022)

Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis
por: Keiner, Cathrine, et al.
Publicado: (2022)

Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis
por: Hu, Gang, et al.
Publicado: (2018)

Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer
por: Zhong, Ailing, et al.
Publicado: (2020)

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio
por: Lee, Soo Jin, et al.
Publicado: (2022)

Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
por: Solmaz, Serife, et al.
Publicado: (2018)

Single and combined use of the platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and systemic immune-inflammation index in gastric cancer diagnosis
por: Zhang, Jingliang, et al.
Publicado: (2023)

Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
por: Yang, Tao, et al.
Publicado: (2021)

The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer
por: Wang, Liqun, et al.
Publicado: (2017)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
por: Zhang, Yan, et al.
Publicado: (2018)

Changes in Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio During Palliative Radiotherapy May Predict Efficacy of Immune Checkpoint Inhibitor as Re-Challenge Treatment in Advanced Gastric Cancer: A Case Report
por: Chen, Jianxin, et al.
Publicado: (2022)

Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Hua, et al.
Publicado: (2016)

Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer
por: Adamkiewicz, Mateusz, et al.
Publicado: (2021)

Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
por: Oh, Dongwook, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jga625tm2nct50j2p45cda82fg